CompareMarketResearchRequest a sample
Home / Healthcare / Point of Care Testing

Healthcare · Market report

Point of Care Testing Market Size, Share and Forecast 2026-2036

The global point of care testing market is worth USD 44.9 bn in 2026 and is forecast to reach USD 88.4 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Glucose monitoring is the largest by product segment.

USD 44.9 bnMarket size 2026
USD 88.4 bnForecast 2036
7.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global point of care testing market is worth USD 44.9 bn in 2026 and is forecast to reach USD 88.4 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Glucose monitoring is the largest by product segment.

ScopeDiagnostic tests performed at or near the patient outside a central laboratory, including glucose, infectious disease, cardiac marker, pregnancy, coagulation, blood gas and urinalysis tests with their readers.
IndustryHealthcare
Value 2025USD 42.0 bn
Value 2026USD 44.9 bn
Value 2036USD 88.4 bn
CAGR 2026-20367.0%
Volume 202612,776 million tests
Volume 203623,910 million tests
Average price 2026USD 3.52 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Point of Care Testing market size and forecast, 2026-2036

Exhibit 1The global point of care testing market is forecast to grow from USD 44.9 bn in 2026 to USD 88.4 bn by 2036, a rise of 97%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 7.0%
Point of Care Testing market value, 2025 to 2036Market value by year. 2025: USD 42.0 bn; 2026: USD 44.9 bn; 2027: USD 48.1 bn; 2028: USD 51.5 bn; 2029: USD 55.1 bn; 2030: USD 58.9 bn; 2031: USD 63.0 bn; 2032: USD 67.4 bn; 2033: USD 72.2 bn; 2034: USD 77.2 bn; 2035: USD 82.6 bn; 2036: USD 88.4 bn. Compound annual growth rate 2026 to 2036: 7.0%.202544.9 bn202663.0 bn203188.4 bn20367.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 44.9 bn
2027USD 48.1 bn
2028USD 51.5 bn
2029USD 55.1 bn
2030USD 58.9 bn
2031USD 63.0 bn
2032USD 67.4 bn
2033USD 72.2 bn
2034USD 77.2 bn
2035USD 82.6 bn
2036USD 88.4 bn

Point of Care Testing market segmentation

By product

Exhibit 2Glucose monitoring is the largest segment by product, with 30.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Point of Care Testing market share by product, 2026Share of 2026 revenue by product. Glucose monitoring: 30.0%; Infectious disease: 22.0%; Other: 16.0%; Cardiometabolic markers: 14.0%; Coagulation and blood gas: 10.0%; Pregnancy and fertility: 8.0%.Glucose monitoring30.0%Infectious disease22.0%Other16.0%Cardiometabolic markers14.0%Coagulation and blood gas10.0%Pregnancy and fertility8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Glucose monitoring30.0%25.2%USD 13.5 bn5.1%
Infectious disease22.0%24.5%USD 9.9 bn8.2%
Cardiometabolic markers14.0%14.9%USD 6.3 bn7.7%
Pregnancy and fertility8.0%6.7%USD 3.6 bn5.1%
Coagulation and blood gas10.0%9.2%USD 4.5 bn6.2%
Other16.0%19.5%USD 7.2 bn9.2%

By end user

Exhibit 3Home and self-testing adds the most revenue by end user, growing from USD 18.0 bn in 2026 to USD 37.4 bn by 2036Estimated revenue in USD by end user, 2026 and 2036 forecast
Point of Care Testing market by end user, 2026 and 2036Revenue by end user in 2026 and 2036. Home and self-testing: USD 18.0 bn in 2026, USD 37.4 bn in 2036, change +108%; Hospitals and clinics: USD 17.1 bn in 2026, USD 32.3 bn in 2036, change +89%; Physician offices and labs: USD 9.9 bn in 2026, USD 18.7 bn in 2036, change +89%.20262036 forecastChangeHome and self-testing+108%18.0 bn37.4 bnHospitals and clinics+89%17.1 bn32.3 bnPhysician offices and labs+89%9.9 bn18.7 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals and clinics38.0%36.6%USD 17.1 bn6.6%
Home and self-testing40.0%42.3%USD 18.0 bn7.6%
Physician offices and labs22.0%21.2%USD 9.9 bn6.6%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Lateral flow immunoassay36.0%32.0%USD 16.2 bn5.8%
Biosensor electrochemical26.0%26.0%USD 11.7 bn7.0%
Molecular point-of-care14.0%22.0%USD 6.3 bn11.9%
Microfluidic and cartridge14.0%12.0%USD 6.3 bn5.4%
Others10.0%8.0%USD 4.5 bn4.6%

By sample

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Blood56.0%52.0%USD 25.2 bn6.2%
Urine14.0%14.0%USD 6.3 bn7.0%
Swab and nasal20.0%24.0%USD 9.0 bn9.0%
Saliva and others10.0%10.0%USD 4.5 bn7.0%

By use model

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Professional use58.0%52.0%USD 26.1 bn5.8%
Over-the-counter home34.0%38.0%USD 15.3 bn8.2%
Telehealth-linked self testing8.0%10.0%USD 3.6 bn9.4%

Top 25 countries for point of care testing by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.5% of 2026 revenue and the 25 countries below together hold 95.1%.

Exhibit 4United States is the largest country market at USD 17.1 bn in 2026, and the three largest countries hold 57.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Point of Care Testing market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 17.1 bn, 38.0%; China: USD 5.4 bn, 12.0%; Germany: USD 3.1 bn, 7.0%; Japan: USD 2.7 bn, 6.0%; France: USD 1.8 bn, 4.0%; United Kingdom: USD 1.8 bn, 4.0%; Italy: USD 1.3 bn, 3.0%; India: USD 1.3 bn, 3.0%; Brazil: USD 1.3 bn, 3.0%; Spain: USD 1.1 bn, 2.5%.United States17.1 bn 38.0%China5.4 bn 12.0%Germany3.1 bn 7.0%Japan2.7 bn 6.0%France1.8 bn 4.0%United Kingdom1.8 bn 4.0%Italy1.3 bn 3.0%India1.3 bn 3.0%Brazil1.3 bn 3.0%Spain1.1 bn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 17.1 bn38.0%USD 30.9 bn6.1%
2ChinaUSD 5.4 bn12.0%USD 12.9 bn9.1%
3GermanyUSD 3.1 bn7.0%USD 5.7 bn6.2%
4JapanUSD 2.7 bn6.0%USD 4.7 bn5.7%
5FranceUSD 1.8 bn4.0%USD 3.3 bn6.2%
6United KingdomUSD 1.8 bn4.0%USD 3.4 bn6.7%
7ItalyUSD 1.3 bn3.0%USD 2.5 bn6.3%
8IndiaUSD 1.3 bn3.0%USD 4.2 bn12.2%
9BrazilUSD 1.3 bn3.0%USD 2.9 bn8.0%
10SpainUSD 1.1 bn2.5%USD 2.1 bn6.6%
11CanadaUSD 1.1 bn2.4%USD 2.1 bn7.0%
12AustraliaUSD 777 mn1.7%USD 1.4 bn5.9%
13South KoreaUSD 575 mn1.3%USD 1.0 bn5.9%
14NetherlandsUSD 463 mn1.0%USD 822 mn5.9%
15MexicoUSD 391 mn0.9%USD 990 mn9.7%
16RussiaUSD 342 mn0.8%USD 610 mn6.0%
17TurkeyUSD 306 mn0.7%USD 769 mn9.7%
18SwitzerlandUSD 274 mn0.6%USD 486 mn5.9%
19PolandUSD 252 mn0.6%USD 637 mn9.7%
20Saudi ArabiaUSD 234 mn0.5%USD 583 mn9.6%
21BelgiumUSD 216 mn0.5%USD 389 mn6.1%
22IndonesiaUSD 202 mn0.5%USD 513 mn9.8%
23ThailandUSD 193 mn0.4%USD 486 mn9.7%
24TaiwanUSD 180 mn0.4%USD 318 mn5.9%
25ArgentinaUSD 171 mn0.4%USD 433 mn9.8%
Rest of worldUSD 2.2 bn4.9%USD 4.1 bn6.3%
Exhibit 5United States and China account for 49% of the USD 43.5 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Point of Care Testing market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 44.9 bn. United States: +USD 13.9 bn; China: +USD 7.5 bn; India: +USD 2.9 bn; Germany: +USD 2.6 bn; Japan: +USD 2.0 bn; 20 other countries: +USD 12.7 bn; Rest of world: +USD 1.9 bn. Market value 2036: USD 88.4 bn.Market value 202644.9 bnUnited States+13.9 bnChina+7.5 bnIndia+2.9 bnGermany+2.6 bnJapan+2.0 bn20 other countries+12.7 bnRest of world+1.9 bnMarket value 203688.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Abbott
  • Roche
  • Danaher
  • Siemens Healthineers
  • QuidelOrtho
  • Becton Dickinson
  • Cepheid

Group 2: Regional and specialist players

  • bioMerieux
  • Sysmex
  • Werfen
  • Nova Biomedical
  • Radiometer
  • PTS Diagnostics
  • Ascensia Diabetes Care
  • LifeScan
  • i-SENS
  • Arkray

Group 3: Emerging and niche players

  • Sinocare
  • Wondfo
  • Meridian Bioscience
  • Trinity Biotech
  • Visby Medical

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the point of care testing market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.0% is calculated from the resulting values.

The market is divided by product, by end user, by technology, by sample, by use model. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the point of care testing market?

The global point of care testing market is estimated at USD 42.0 bn in 2025 and USD 44.9 bn in 2026.

How fast will the point of care testing market grow?

It is forecast to reach USD 88.4 bn by 2036, a compound annual growth rate of 7.0% from 2026, an increase of USD 43.5 bn.

Which country is the largest market for point of care testing?

United States is the largest market by revenue at USD 17.1 bn in 2026, 38.0% of the global total. The three largest countries together hold 57.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 12.2% a year from 2026 to 2036.

Which point of care testing segment is largest?

In the by product split, Glucose monitoring is the largest segment with 30.0% of 2026 revenue.

Who are the leading point of care testing companies?

Global leaders include Abbott, Roche, Danaher, Siemens Healthineers.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Pharmacy Point-of-Care Respiratory Diagnostic Panels →

All Healthcare markets →

Request a sample